| Literature DB >> 28128900 |
Lang Feng1, Jian Song1, Daoxin Zhang1, Ye Tian1.
Abstract
OBJECTIVE: To analyze the mentor-based learning curve of one single surgeon with transurethral plasmakinetic enucleation and resection of prostate (PKERP) prospectively.Entities:
Keywords: Prostate ; Transurethral Resection of Prostate
Mesh:
Year: 2017 PMID: 28128900 PMCID: PMC5433363 DOI: 10.1590/S1677-5538.IBJU.2016.0237
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Patients’ demographic and perioperative characteristics.
| Parameters | Group 1 (n=40) | Group 2 (n=50) | Group 3 (n=40) | P value |
|---|---|---|---|---|
| Age(years) | 72.8±7.3 | 70.9±8.1 | 72.1±8.7 | 0.528 |
| Prostate size (mL) | 75.2±28.1 | 81.8±23.9 | 78.9±24.9 | 0.476 |
| PSA(ng/dL) | 4.19±1.78 | 4.68±2.24 | 4.39±1.92 | 0.512 |
| IPSS | 21.8±2.3 | 22.5±1.9 | 21.7±1.4 | 0.110 |
| QoL(score) | 3.8±0.7 | 3.7±0.6 | 3.9±0.6 | 0.670 |
| Qmax(mL/s) | 7.6±2.5 | 7.7±2.6 | 6.9±2.2 | 0.252 |
| PVR(mL) | 86.6±37.7 | 101.7±47.8 | 94.7±40.7 | 0.211 |
| Operation time(min) | 79.2±24.6 | 71.3±23.9 | 67.9±18.8 | 0.040* |
| Enucleation time (min) | 33.2±10.4 | 29.0±9.4 | 28.3±9.5 | 0.022* |
| Resection time (min) | 45.9±17.1 | 42.0±15.4 | 39.8±11.8 | 0.115 |
| Resected weight (g) | 48.3±17.5 | 44.1±13.9 | 48.2±20.4 | 0.323 |
| Operation efficiency (g/min) | 0.59±0.09 | 0.61±0.08 | 0.68±0.13 | 0.036* |
| Enucleation efficiency (g/min) | 1.49±0.39 | 1.56±0.30 | 1.71±0.44 | 0.019* |
| Resection efficiency (g/min) | 1.04±0.17 | 1.12±0.15 | 1.29±0.35 | 0.027* |
| FMA | 4.1±3.0 | 2.1±2.2 | NA | <0.01* |
| Catheter time (d) | 2.3±1.2 | 2.3±1.3 | 2.0±1.1 | 0.378 |
| Hospital stay (d) | 2.9±1.2 | 3.0±1.4 | 2.8±1.1 | 0.728 |
Data presented as mean±standard deviation. *p<0.05
PSA = prostate-specific antigen; IPSS = International Prostate Symptom Score; QoL = quality of life; PVR = postvoid residual volume; FMA = frequency of mentor advice; Group 1 = surgeon A, cases 1-40; Group 2 = surgeon A, cases 41-90; Group 3 = surgeon C, cases 1-40; NA= not applicable.
Preoperative characteristics and follow-up data.
| Parameters | Group 1 (n=40) | Group 2 (n=50) | Group 3 (n=40) | P-value |
|---|---|---|---|---|
|
| ||||
| Preop | 21.8±2.3 | 22.5±1.9 | 21.7±1.4 | 0.110 |
| 3 month | 8.1±2.8 | 8.2±2.7 | 7.5±2.5 | 0.432 |
| 6 month | 7.3±2.4 | 7.7±2.1 | 7.1±2.1 | 0.395 |
| 12 month | 6.8±1.9 | 6.9±1.8 | 6.7±1.8 | 0.925 |
| P value | <0.001* | <0.001* | <0.001* | |
|
| ||||
| Preop | 3.8±0.7 | 3.7±0.6 | 3.9±0.6 | 0.670 |
| 3 month | 1.7±0.7 | 1.8±0.7 | 1.7±0.6 | 0.878 |
| 6 month | 1.5±0.5 | 1.6±0.7 | 1.5±0.5 | 0.789 |
| 12 month | 1.4±0.5 | 1.4±0.4 | 1.4±0.5 | 0.786 |
| P value | <0.001* | <0.001* | <0.001* | |
|
| ||||
| Preop | 7.6±2.5 | 7.7±2.6 | 6.9±2.2 | 0.252 |
| 3 month | 20.2±2.8 | 20.7±2.9 | 20.9±2.6 | 0.523 |
| 6 month | 21.2±2.3 | 21.3±2.3 | 21.4±2.1 | 0.883 |
| 12 month | 21.5±1.8 | 21.6±1.7 | 21.7±1.9 | 0.935 |
| P value | <0.001* | <0.001* | <0.001* | |
|
| ||||
| Preop | 86.6±37.7 | 101.7±47.8 | 94.7±40.7 | 0.211 |
| 3 month | 11.1±4.2 | 10.9±4.5 | 10.3±3.7 | 0.647 |
| 6 month | 10.0±2.8 | 9.9±3.6 | 9.3±3.1 | 0.549 |
| 12 month | 9.4±2.3 | 9.6±2.7 | 9.2±3.1 | 0.796 |
| P value | <0.001* | <0.001* | <0.001* |
Data presented as mean±standard deviation. *p<0.001
Preop = preoperative; IPSS = International Prostate Symptom Score; QoL = quality of life; PVR = postvoid residual; Group 1 = surgeon A, cases 1-40; Group 2 = surgeon A, cases 41-90; Group 3 = surgeon C, cases 1-40.
Complications of PKERP according to the CLAVIEN-DINDO grade system.
| Complications (n%) | Group 1 (n=40) | Group 2 (n=50) | Group 3 (n=40) |
|---|---|---|---|
|
| |||
| Capsule perforation | 3(7.5%) | 0 | 0 |
| Bladder mucosa damage | 2(5%) | 0 | 0 |
| Transient incontinence | 3(7.5%) | 2(4%) | 1(2.5%) |
|
| |||
| Blood transfusion | 2(5%) | 1(2%) | 1(2.5%) |
| Urinary tract infection | 2(5%) | 1(2%) | 1(2.5%) |
| Re-catheterization | 1(2.5%) | 1(2%) | 0 |
|
| |||
| Hematuresis need reoperation | 1(2.5%) | 0 | 0 |
|
| |||
| Urethral stricture | 1(2.5%) | 1(2%) | 0 |
| Bladder-neck contracture | 1(2.5%) | 0 | 0 |
Data presented as n%.
PKERP = transurethral plasmakinetic enucleation and resection of prostate; Group 1 = surgeon A, cases 1-40; Group 2 = surgeon A, cases 41-90; Group 3 = surgeon C, cases 1-40.
Figura 1(A): Comparison of operation efficiency over the number of PKERP cases performed by surgeon A (n=90); (B): Comparison of enucleation efficiency over the number of PKERP cases performed by surgeon A (n=90); (C): Comparison of resection efficiency over the number of PKERP cases performed by surgeon A (n=90); (D): Comparison of FMA over the number of PKERP cases performed by surgeon A (n=90).
Figura 2(A): Comparison of operation efficiency between the three groups; (B): Comparison of enucleation efficiency between the three groups; (C): Comparison of resection efficiency between the three groups.